Singapore Clinical Research Institute (SCRI)

Singapore Clinical Research Institute (SCRI) is dedicated to enhancing the standards of human clinical research, aspiring to position SCRI and Singapore as a leading ASEAN hub for clinical research excellence. As a wholly-owned subsidiary of Ministry of Health Holdings, Singapore, Singapore Clinical Research Institute (SCRI) is committed to improving patient care through the design and conduct of high-quality, cutting-edge clinical studies. The primary address of Singapore Clinical Research Institute (SCRI) is 23 Rochester Park, #06-01, Singapore, 139234, SG.

Singapore Clinical Research Institute (SCRI) supports a wide range of studies, from proof-of-concept to late-phase clinical trials and epidemiological studies. Collaborating with academic, public-sector, and industry sponsors, Singapore Clinical Research Institute (SCRI) enhances Singapore’s clinical research capabilities and strengthens its expertise in executing multi-site, multi-national research. The institute also focuses on the development of regional clinical research networks.

In its mission to build clinical research capacity in Singapore and the region, Singapore Clinical Research Institute (SCRI) spearheads the planning and delivery of educational and training programs. These programs cover various aspects of clinical research, ensuring a highly skilled workforce. We invite the management team to create a customized and exclusive company showcase and product listing on our platform to further highlight the exceptional work of Singapore Clinical Research Institute (SCRI).